Stay updated on Pediatric MRD+ CD22+ ALL: Inotuzumab Clinical Trial
Sign up to get notified when there's something new on the Pediatric MRD+ CD22+ ALL: Inotuzumab Clinical Trial page.

Latest updates to the Pediatric MRD+ CD22+ ALL: Inotuzumab Clinical Trial page
- Check6 days agoChange DetectedA new history revision 'Revision: v3.6.4' was added to the study record, replacing the previous 'Revision: v3.6.3' entry. This reflects an updated release note in the record history without altering the underlying study data.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedAdds a new revision entry (v3.6.3) to the study's version history and removes the previous revision (v3.6.2) from the list. This update reflects a metadata versioning change in the study record rather than content changes to the study itself.SummaryDifference0.1%

- Check35 days agoChange DetectedNew revision entry v3.6.2 was added to the study history and the previous revision v3.6.0 was removed. This updates the history to reflect the latest version of the page.SummaryDifference0.1%

- Check49 days agoChange DetectedHistorically the study record includes a new recruitment status 'No longer looking for participants', indicating recruitment has stopped. The revision tag has been updated to v3.6.0, replacing the prior v3.5.5 entry.SummaryDifference0.5%

- Check56 days agoChange DetectedNew revision entry added: v3.5.5 replaces v3.5.4 in the page history, indicating an updated revision note. This update is a technical version bump and does not modify study data or public content.SummaryDifference0.1%

- Check77 days agoChange DetectedUpdated the record history by adding a new revision entry v3.5.4 and removing the previous v3.5.3, updating the historical revision list to reflect the latest published revision.SummaryDifference0.1%

Stay in the know with updates to Pediatric MRD+ CD22+ ALL: Inotuzumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric MRD+ CD22+ ALL: Inotuzumab Clinical Trial page.